Literature DB >> 23180080

Populus nigra L. bud absolute: a case study for a strategy of analysis of natural complex substances.

Patrizia Rubiolo1, Cristina Casetta, Cecilia Cagliero, Hugues Brevard, Barbara Sgorbini, Carlo Bicchi.   

Abstract

The new European regulations (e.g., REACH) require that Natural Complex Substances such as essential oils, absolutes, concretes, and resinoids are registered. This need implies that the chemical composition of these complex mixtures is characterized as exhaustively as possible in view of defining their toxicological risk. This study proposes an analysis strategy to be applied to the chemical characterization of poplar absolute as an example of Natural Complex Substances of vegetable origin. In the first part, the proposed strategy is described, and the advantages and the limitations related to the combination of conventional analytical techniques such as gas chromatography (GC) without and with sample derivatization and high-performance liquid chromatography (HPLC) are critically discussed. In the second part, the qualitative data obtained with GC and HPLC analysis of poplar bud absolute confirm the sample complexity which mainly consists of phenolic components. Fourteen compounds (i.e., phenolic acids, phenylpropanoids, and flavonoids) were then chosen as markers representative of the main classes of components characterizing poplar bud absolute. The marker quantitation carried out by GC-SIM-MS and HPLC-PDA analyses gives similar results confirming the reliability of both techniques. These results demonstrate that conventional analytical techniques can positively and effectively contribute to the study of the the composition of Natural Complex Substances, i.e., matrices for which highly effective separation is necessary, consisting mainly of isomers or homologous components. The combination of GC and HPLC techniques is ever more necessary for routine quality control when conventional instrumentations are used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180080     DOI: 10.1007/s00216-012-6537-y

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  5 in total

1.  Extracts of Poplar Buds (Populus balsamifera L., Populus nigra L.) and Lithuanian Propolis: Comparison of Their Composition and Biological Activities.

Authors:  Monika Stanciauskaite; Mindaugas Marksa; Mindaugas Liaudanskas; Liudas Ivanauskas; Marija Ivaskiene; Kristina Ramanauskiene
Journal:  Plants (Basel)       Date:  2021-04-21

2.  Antimicrobial activity, in vitro anticancer effect (MCF-7 breast cancer cell line), antiangiogenic and immunomodulatory potentials of Populus nigra L. buds extract.

Authors:  Brigitta Kis; Ioana Zinuca Pavel; Stefana Avram; Elena Alina Moaca; Martina Herrero San Juan; Anja Schwiebs; Heinfried H Radeke; Delia Muntean; Zorita Diaconeasa; Daliana Minda; Camelia Oprean; Florina Bojin; Cristina Adriana Dehelean; Codruta Soica; Corina Danciu
Journal:  BMC Complement Med Ther       Date:  2022-03-16

3.  Antifungal and antibacterial metabolites from a French poplar type propolis.

Authors:  Séverine Boisard; Anne-Marie Le Ray; Anne Landreau; Marie Kempf; Viviane Cassisa; Catherine Flurin; Pascal Richomme
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-22       Impact factor: 2.629

4.  Comparisons of ethanol extracts of chinese propolis (poplar type) and poplar gums based on the antioxidant activities and molecular mechanism.

Authors:  Jianglin Zhang; Xueping Cao; Shun Ping; Kai Wang; Jinhu Shi; Cuiping Zhang; Huoqing Zheng; Fuliang Hu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

5.  Inorganic Element Determination of Romanian Populus nigra L. Buds Extract and In Vitro Antiproliferative and Pro-Apoptotic Evaluation on A549 Human Lung Cancer Cell Line.

Authors:  Brigitta Kis; Ioana Zinuca Pavel; Daniela Haidu; Mariana Nela Ștefănuț; Zorița Diaconeasa; Elena-Alina Moacă; Cristina Adriana Dehelean; Simona Șipos; Alexandra Ivan; Corina Danciu
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.